A Nomination Committee consisting of shareholder representatives and the Chairman of the Board of Directors has been formed for Biotage AB. The Nomination Committee shall, before the Annual General Meeting 2015, prepare proposal for the election of Chairman and other members of the Board of Directors, the election of Chairman of the Annual Meeting, election of Auditors, the determination of fees and matters pertaining thereto. The members of the Nominations Committee are: Ove Mattsson, Chairman of the Board, holding by endowment insurances Anders Walldov, Brohuvudet AB and direct holding Pia Axelsson, Fjärde AP-fonden Andreas Bladh, Varenne AB Shareholders wishing to submit a proposal for members of the Board of Directors may do so by sending e-mail to the Chairman of the Board of Directors of Biotage AB at: info@biotage.com The Annual General Meeting 2015 in Biotage will be held on Tuesday, April 15, 2015 at 4:00pm CET in Uppsala. Shareholders who want to have a matter addressed at the Annual General Meeting 2015 must submit such a proposal to the same address as above (subject “Annual General Meeting 2015” for the e-mail and the letter, respectively) seven weeks in advance of the meeting at the latest. Future information reporting dates from Biotage: +---------------------------------------+---------------------------+ |Year-End Report 2014 |12 February 2015 | +---------------------------------------+---------------------------+ |Publication of the Annual Report |Week 14 2015 | +---------------------------------------+---------------------------+ |Annual General Meeting 2015 |28 April 2015 at 4:00pm CET| +---------------------------------------+---------------------------+ |Interim Report January – March 2015 |28 April 2015 | +---------------------------------------+---------------------------+ |Interim Report January – June 2015 |13 August 2015 | +---------------------------------------+---------------------------+ |Interim Report January – September 2015|30 October 2015 | +---------------------------------------+---------------------------+ |Year-End Report 2015 |11 February 2016 | +---------------------------------------+---------------------------+ Biotage discloses the information provided herein pursuant to the Swedish Securities Markets Act and/or the Swedish Financial Instruments Trading Act. The information was submitted for publication at 11:00am on 23 October 2014. Contact: SE-751 03 Uppsala Torben Jörgensen, President and CEO Tel+46 18 56 59 00 Tel: +46 707 49 05 84, torben.jorgensen@biotage.com www.biotage.com About Biotage Biotage offers efficient separation technologies for use within analytical all the way up to industrial scale as well as highly qualitative solutions for analytical chemistry in research and at commercial analytical laboratories. Biotage’s products are used by e.g. governmental authorities, academic institutions, pharma and food industries. The company is headquartered in Uppsala and has offices in the US, UK, China and Japan. Biotage has approx. 290 employees and had sales of 445 MSEK in 2013. Biotage is listed on the NASDAQ OMX Nordic Stockholm stock exchange. Website: www.biotage.com
Biotage appoints Nomination Committee and publishes financial calendar 2014 and 2015
| Source: Biotage AB
Attachments
